GA-map® Discovery
Short turnaround
Easy data processing
Documented specificity
Flexible workflow
Microbiome profiling at your laboratory
GA-map® Discovery enables time- and cost-efficient microbiome analysis without compromising on the results quality. With its 174 documented bacteria markers, the assay facilitates microbiome composition measurement in just 2 days.
The assay is compatible with all extraction systems optimized for specific sample types.
Microbiome composition results are generated with no need for complicated data processing or multi-step sample preparation.
GA-map® Discovery assay specifications
Sample type
Feces, saliva, other
Read-out platform
Luminex® 200™, FLEXMAP 3D®, xMAP INTELLIFLEX®
Assay time
12 hours (pre-extracted samples)
Output
Normalized signals in a single Microsoft Excel file
Assay format
174 analytes, 3-wells/sample format
Fast and easy microbiome composition results
GA-map® Discovery workflow enables fast data generation without the need for extensive data processing steps.
Luminex® instrument-generated data files are readily processed in an online normalization tool.
The normalized signals for each marker, delivered in a single Microsoft Excel file, give you a solid basis for data presentation tailored to your research.
Visual microbiome profiles can be generated for individual samples or sample cohorts using the normalized signal values.
Assay applications
GA-map® Discovery is a targeted research panel investigating microbiota composition in gut or oral samples. The assay was designed for use in research, but the method standardization and marker documentation make it adaptable to different applications:
- Standardized microbiome panel for laboratories processing high volumes of research samples.
- Assay development with disease/application specific sub-panels.
- Validation tool for basic research findings.
Broad target coverage
GA-map® Discovery bacteria marker panel covers a broad range of gut and oral bacteria connected to gastrointestinal and metabolic health and disease.
The pre-selected bacteria panel comprises of 174 bacterial markers, covering bacteria species spanning over 110 genera.
The markers include bacteria from known clinically important groups, ranging from probiotic strains to enteric and oral opportunistic pathogens.
Follow the link below to download the complete target list.